English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)

Clinical Trials

Givinostat for BMD - ITF BECKER

Phase II Study (completed)

Official Title:A randomised, double blind, placebo controlled study to evaluate the micro-macroscopic effects on muscles, the safety and tolerability, and the efficacy of Givinostat in patients with Becker Muscular Dystrophy (DSC/14/2357/53).

Purpose: The main objective of the study was to evaluate whether the beneficial histological effects observed with Givinostat in the DMD patients could be extended to Becker patients.

Location: Europe (Italy and the Netherland).


For more information and enrollment status, please visit www.clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT03238235) or https://www.clinicaltrialsregister.eu/ctr-search/search.